written by reader Recent Surge in Gene Editing Stocks

by bryantrd1 | January 28, 2022 1:54 pm

I subscribe to multiple services and have seen quite a few recommendations for gene editing stocks (CRSP, BEAM, EDIT, etc). Is there some movement in this space? I bought these things 2 years ago and not much has happened.

Source URL: https://www.stockgumshoe.com/2022/01/microblog-recent-surge-in-gene-editing-stocks/


2 responses to “written by reader Recent Surge in Gene Editing Stocks”

  1. quazime says:

    I am up:

    CRSP – 38% in 4 years, on Feb 2021 I was up 150%!

    I sold EDIT and I have been wary of these gene editing investments for a while.

  2. bunion132 says:

    Yes, there seems to be a bit of upward movement in the stocks you mentioned, but the turnaround applies to all sectors at this point due to the overdone sell-off last month.

    It might be worth noting, however, that Doc Eifrig’s freebie reco during Stansberry’s most recent webinar (titled “2022 Kickoff”, aired Jan 27th) was Pfizer — not for the vaccines but for its partnership with Beam to test a newer form of gene editing.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.